RepliCel Life Sciences Inc. announced that Mr. Peter Lowry will not be standing for re-election as a director at the Meeting. The Board will appoint a new member to the NCCG Committee after the Meeting.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0428 USD | +4.99% | -.--% | -4.89% |
18/04 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
2023 | RepliCel Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-4.89% | 2.78M | |
+3.27% | 108B | |
+10.37% | 105B | |
+1.57% | 23.46B | |
-12.83% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.41% | 17.19B | |
+5.88% | 13.99B | |
+36.79% | 12.53B |
- Stock Market
- Equities
- REPCF Stock
- News RepliCel Life Sciences Inc.
- Replicel Life Sciences Inc. Announces That Peter Lowry Will Not Be Standing for Re-Election as A Director